134 related articles for article (PubMed ID: 576837)
21. Inhibition of mammary dysplasia in estrogen-treated C3H-HeJ female mice by treatment with 2-bromo-alpha-ergocryptine.
Brooks CL; Welsch CW
Proc Soc Exp Biol Med; 1974 Feb; 145(2):484-7. PubMed ID: 4814143
[No Abstract] [Full Text] [Related]
22. Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice.
Mori T; Bern HA; Mills KT; Young PN
J Natl Cancer Inst; 1976 Nov; 57(5):1057-62. PubMed ID: 187788
[TBL] [Abstract][Full Text] [Related]
23. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Delitala G; Masala A; Alagna S; Devilla L
IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
[No Abstract] [Full Text] [Related]
24. [Contraceptives and Mammary Tumours in Mice (author's transl)].
Coezy E
Contracept Fertil Sex (Paris); 1976 Sep; 4(5):319-29. PubMed ID: 62685
[No Abstract] [Full Text] [Related]
25. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Welsch CW; Brown CK; Goodrich-Smith M; Van J; Denenberg B; Anderson TM; Brooks CL
J Natl Cancer Inst; 1979 Nov; 63(5):1211-4. PubMed ID: 116049
[TBL] [Abstract][Full Text] [Related]
26. Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: a preliminary report.
Kirschstein RL; Rabson AS; Rusten GW
J Natl Cancer Inst; 1972 Feb; 48(2):551-6. PubMed ID: 4347040
[No Abstract] [Full Text] [Related]
27. LACK OF EFFECT OF NORETHYNODREL (ENOVID) ON METHYLCHOLANTHRENE-INDUCED MAMMARY CARCINOGENESIS IN FEMALE RATS.
GRUENSTEIN M; SHAY H; SHIMKIN MB
Cancer Res; 1964 Oct; 24():1656-8. PubMed ID: 14234009
[No Abstract] [Full Text] [Related]
28. Alteration of convulsive threshold and conditioned avoidance response in mice fed diets containing contraceptive steroids.
Yen-Koo HC; Balazs T
Drug Chem Toxicol; 1984; 7(6):541-9. PubMed ID: 6534731
[TBL] [Abstract][Full Text] [Related]
29. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
Muldoon TG
Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
[TBL] [Abstract][Full Text] [Related]
30. Effects of a cyclic steroid contraceptive regimen on mammary gland tumor induction in rats.
Stern E; Mickey MR
Br J Cancer; 1969 Jun; 23(2):391-400. PubMed ID: 5788048
[No Abstract] [Full Text] [Related]
31. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Medina D
J Natl Cancer Inst; 1977 Apr; 58(4):1107-10. PubMed ID: 576622
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
Sinha YN; Salocks CB; VanderLaan WP
Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
[TBL] [Abstract][Full Text] [Related]
33. Luteal 20alpha-hydroxy steroid dehydrogenase and the formation of delta4-3-oxo steroids in the rat after weaning or treatment with 2-bromo-alpha-ergocryptine during lactation.
Rodway RG; Kuhn NJ
Biochem J; 1975 Dec; 152(3):445-8. PubMed ID: 1227499
[TBL] [Abstract][Full Text] [Related]
34. Studies in mice on the mutagenicity of two contraceptive drugs.
Wallace ME; Badr FM; Badr RS
J Med Genet; 1979 Jun; 16(3):206-9. PubMed ID: 469899
[TBL] [Abstract][Full Text] [Related]
35. Oral contraception and venous thrombosis.
Tyler ET
JAMA; 1963 Jul; 185(2):131-2. PubMed ID: 12255487
[TBL] [Abstract][Full Text] [Related]
36. Effect of 2-bromo-alpha-ergocryptine (CB-154) on estrogen induced growth of the rat prostate.
Resnick MI; Grayhack JT
Invest Urol; 1978 Mar; 15(5):392-4. PubMed ID: 565341
[TBL] [Abstract][Full Text] [Related]
37. 6-Methyl-8-beta-ergoline-acetonitrile (MEA)-induced suppression of mammary tumorigenesis in C3H/HeJ female mice.
Welsch CW; Gribler C; Clemens JA
Eur J Cancer (1965); 1974 Sep; 10(9):595-600. PubMed ID: 4477735
[No Abstract] [Full Text] [Related]
38. Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
Gala RR; Boss RS
Proc Soc Exp Biol Med; 1975 Jun; 149(2):330-2. PubMed ID: 1153405
[TBL] [Abstract][Full Text] [Related]
39. Endocrinology of reproduction in the female beagle dog and its significance in mammary gland tumorigenesis.
Gräf KJ; El Etreby MF
Acta Endocrinol Suppl (Copenh); 1979; 222():1-34. PubMed ID: 285559
[TBL] [Abstract][Full Text] [Related]
40. Lack of hepatogenotoxicity of oral contraceptive steroids.
Yager JD; Fifield DS
Carcinogenesis; 1982; 3(6):625-8. PubMed ID: 7116555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
